Logo image of HUN

HUNTSMAN CORP (HUN) Stock Fundamental Analysis

NYSE:HUN - New York Stock Exchange, Inc. - US4470111075 - Common Stock - Currency: USD

16.51  +0.35 (+2.17%)

After market: 16.51 0 (0%)

Fundamental Rating

3

HUN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. Both the profitability and financial health of HUN have multiple concerns. While showing a medium growth rate, HUN is valued expensive at the moment. HUN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year HUN has reported negative net income.
HUN had a positive operating cash flow in the past year.
HUN had positive earnings in each of the past 5 years.
In the past 5 years HUN always reported a positive cash flow from operatings.
HUN Yearly Net Income VS EBIT VS OCF VS FCFHUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

1.2 Ratios

HUN has a worse Return On Assets (-1.62%) than 72.29% of its industry peers.
Looking at the Return On Equity, with a value of -3.85%, HUN is doing worse than 66.27% of the companies in the same industry.
With a Return On Invested Capital value of 0.48%, HUN is not doing good in the industry: 75.90% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for HUN is in line with the industry average of 6.58%.
The last Return On Invested Capital (0.48%) for HUN is well below the 3 year average (6.17%), which needs to be investigated, but indicates that HUN had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.62%
ROE -3.85%
ROIC 0.48%
ROA(3y)6.04%
ROA(5y)7.35%
ROE(3y)13.28%
ROE(5y)18.1%
ROIC(3y)6.17%
ROIC(5y)5.32%
HUN Yearly ROA, ROE, ROICHUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1.3 Margins

HUN's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 0.58%, HUN is not doing good in the industry: 75.90% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of HUN has declined.
HUN has a Gross Margin of 13.86%. This is in the lower half of the industry: HUN underperforms 75.90% of its industry peers.
In the last couple of years the Gross Margin of HUN has declined.
Industry RankSector Rank
OM 0.58%
PM (TTM) N/A
GM 13.86%
OM growth 3Y-24.67%
OM growth 5Y-31.18%
PM growth 3Y-54.18%
PM growth 5Y-17.9%
GM growth 3Y-6.74%
GM growth 5Y-8.57%
HUN Yearly Profit, Operating, Gross MarginsHUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HUN is destroying value.
The number of shares outstanding for HUN has been reduced compared to 1 year ago.
The number of shares outstanding for HUN has been reduced compared to 5 years ago.
The debt/assets ratio for HUN is higher compared to a year ago.
HUN Yearly Shares OutstandingHUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
HUN Yearly Total Debt VS Total AssetsHUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 1.81 indicates that HUN is not a great score, but indicates only limited risk for bankruptcy at the moment.
HUN has a Altman-Z score of 1.81. This is comparable to the rest of the industry: HUN outperforms 43.37% of its industry peers.
HUN has a debt to FCF ratio of 32.05. This is a negative value and a sign of low solvency as HUN would need 32.05 years to pay back of all of its debts.
The Debt to FCF ratio of HUN (32.05) is worse than 61.45% of its industry peers.
A Debt/Equity ratio of 0.49 indicates that HUN is not too dependend on debt financing.
HUN has a Debt to Equity ratio of 0.49. This is in the better half of the industry: HUN outperforms 62.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 32.05
Altman-Z 1.81
ROIC/WACC0.06
WACC8.31%
HUN Yearly LT Debt VS Equity VS FCFHUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B

2.3 Liquidity

HUN has a Current Ratio of 1.47. This is a normal value and indicates that HUN is financially healthy and should not expect problems in meeting its short term obligations.
HUN has a Current ratio of 1.47. This is in the lower half of the industry: HUN underperforms 72.29% of its industry peers.
A Quick Ratio of 0.83 indicates that HUN may have some problems paying its short term obligations.
HUN has a worse Quick ratio (0.83) than 78.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.83
HUN Yearly Current Assets VS Current LiabilitesHUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

The earnings per share for HUN have decreased strongly by -104.92% in the last year.
HUN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -35.91% yearly.
HUN shows a decrease in Revenue. In the last year, the revenue decreased by -5.84%.
The Revenue has been decreasing by -4.28% on average over the past years.
EPS 1Y (TTM)-104.92%
EPS 3Y-28.38%
EPS 5Y-35.91%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-5.84%
Revenue growth 3Y0.51%
Revenue growth 5Y-4.28%
Sales Q2Q%2.26%

3.2 Future

The Earnings Per Share is expected to grow by 48.66% on average over the next years. This is a very strong growth
HUN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.52% yearly.
EPS Next Y-78.91%
EPS Next 2Y27.85%
EPS Next 3Y48.66%
EPS Next 5YN/A
Revenue Next Year-0.16%
Revenue Next 2Y2.13%
Revenue Next 3Y3.21%
Revenue Next 5Y8.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HUN Yearly Revenue VS EstimatesHUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
HUN Yearly EPS VS EstimatesHUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

HUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 28.06, the valuation of HUN can be described as expensive.
Based on the Price/Forward Earnings ratio, HUN is valued a bit more expensive than 66.27% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, HUN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 28.06
HUN Price Earnings VS Forward Price EarningsHUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400

4.2 Price Multiples

HUN's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, HUN is valued a bit more expensive than 60.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 49.24
EV/EBITDA 13.56
HUN Per share dataHUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

HUN's earnings are expected to grow with 48.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.85%
EPS Next 3Y48.66%

8

5. Dividend

5.1 Amount

HUN has a Yearly Dividend Yield of 5.79%, which is a nice return.
HUN's Dividend Yield is rather good when compared to the industry average which is at 3.24. HUN pays more dividend than 91.57% of the companies in the same industry.
HUN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 5.79%

5.2 History

On average, the dividend of HUN grows each year by 7.58%, which is quite nice.
HUN has been paying a dividend for at least 10 years, so it has a reliable track record.
HUN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.58%
Div Incr Years4
Div Non Decr Years17
HUN Yearly Dividends per shareHUN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

HUN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of HUN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-142.86%
EPS Next 2Y27.85%
EPS Next 3Y48.66%
HUN Yearly Income VS Free CF VS DividendHUN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

HUNTSMAN CORP

NYSE:HUN (2/4/2025, 8:04:00 PM)

After market: 16.51 0 (0%)

16.51

+0.35 (+2.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-17 2025-02-17/amc
Inst Owners86.49%
Inst Owner Change-0.21%
Ins Owners5.89%
Ins Owner Change-0.11%
Market Cap2.86B
Analysts69.09
Price Target21.58 (30.71%)
Short Float %3.61%
Short Ratio2.49
Dividend
Industry RankSector Rank
Dividend Yield 5.79%
Yearly Dividend0.95
Dividend Growth(5Y)7.58%
DP-142.86%
Div Incr Years4
Div Non Decr Years17
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.2%
Min EPS beat(2)-1.96%
Max EPS beat(2)4.35%
EPS beat(4)1
Avg EPS beat(4)-5.41%
Min EPS beat(4)-24.01%
Max EPS beat(4)4.35%
EPS beat(8)2
Avg EPS beat(8)-13.33%
EPS beat(12)5
Avg EPS beat(12)-6.72%
EPS beat(16)9
Avg EPS beat(16)-2.57%
Revenue beat(2)0
Avg Revenue beat(2)-2.49%
Min Revenue beat(2)-3.32%
Max Revenue beat(2)-1.66%
Revenue beat(4)1
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-3.32%
Max Revenue beat(4)4.39%
Revenue beat(8)2
Avg Revenue beat(8)-1.57%
Revenue beat(12)2
Avg Revenue beat(12)-2.51%
Revenue beat(16)4
Avg Revenue beat(16)-2.41%
PT rev (1m)-9.43%
PT rev (3m)-17.51%
EPS NQ rev (1m)-17.33%
EPS NQ rev (3m)-163.64%
EPS NY rev (1m)-16.74%
EPS NY rev (3m)-63.77%
Revenue NQ rev (1m)-0.82%
Revenue NQ rev (3m)-7.19%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.06
P/S 0.48
P/FCF 49.24
P/OCF 10.42
P/B 0.92
P/tB 1.37
EV/EBITDA 13.56
EPS(TTM)-0.03
EYN/A
EPS(NY)0.59
Fwd EY3.56%
FCF(TTM)0.34
FCFY2.03%
OCF(TTM)1.58
OCFY9.59%
SpS34.61
BVpS17.85
TBVpS12.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.62%
ROE -3.85%
ROCE 0.61%
ROIC 0.48%
ROICexc 0.51%
ROICexgc 0.62%
OM 0.58%
PM (TTM) N/A
GM 13.86%
FCFM 0.97%
ROA(3y)6.04%
ROA(5y)7.35%
ROE(3y)13.28%
ROE(5y)18.1%
ROIC(3y)6.17%
ROIC(5y)5.32%
ROICexc(3y)7.61%
ROICexc(5y)6.46%
ROICexgc(3y)9.48%
ROICexgc(5y)7.86%
ROCE(3y)7.81%
ROCE(5y)6.74%
ROICexcg growth 3Y-26.3%
ROICexcg growth 5Y-31.4%
ROICexc growth 3Y-26.13%
ROICexc growth 5Y-33.05%
OM growth 3Y-24.67%
OM growth 5Y-31.18%
PM growth 3Y-54.18%
PM growth 5Y-17.9%
GM growth 3Y-6.74%
GM growth 5Y-8.57%
F-Score3
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 32.05
Debt/EBITDA 4.74
Cap/Depr 76.06%
Cap/Sales 3.61%
Interest Coverage 0.44
Cash Conversion 85.89%
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 0.83
Altman-Z 1.81
F-Score3
WACC8.31%
ROIC/WACC0.06
Cap/Depr(3y)98.36%
Cap/Depr(5y)96.91%
Cap/Sales(3y)3.87%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-104.92%
EPS 3Y-28.38%
EPS 5Y-35.91%
EPS Q2Q%-33.33%
EPS Next Y-78.91%
EPS Next 2Y27.85%
EPS Next 3Y48.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.84%
Revenue growth 3Y0.51%
Revenue growth 5Y-4.28%
Sales Q2Q%2.26%
Revenue Next Year-0.16%
Revenue Next 2Y2.13%
Revenue Next 3Y3.21%
Revenue Next 5Y8.52%
EBIT growth 1Y-79.17%
EBIT growth 3Y-24.29%
EBIT growth 5Y-34.12%
EBIT Next Year111.23%
EBIT Next 3Y50.63%
EBIT Next 5YN/A
FCF growth 1Y-94.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-80.34%
OCF growth 3Y-6.17%
OCF growth 5Y-27.63%